Treatment of recurrent small cell lung cancer
10.3760/cma.j.issn.1673-422X.2012.05.015
- VernacularTitle:复发性小细胞肺癌治疗进展
- Author:
Lan SHAO
;
Yiping ZHANG
- Publication Type:Journal Article
- Keywords:
Small cell lung cancer;
Recurrence;
Treatment
- From:
Journal of International Oncology
2012;39(5):373-376
- CountryChina
- Language:Chinese
-
Abstract:
Small-cell lung cancer (SCLG) relapses in the majority of patients,even though most patients respond to first-line therapy.Subsequent therapy can provide significant palliation and prolongation of survival for many patients. At present,topotecan is considered the standard second-line chemotherapy.Recently,amrubicin has also shown more favorable antitumor activity,and is the most promising at present.Unfortunately,targeted agents have failed to demonstrate effectiveness for SCLC.
